A Comparative Study Between Desmopressim and Imipramine in the Management of Nocturnal Enuresis

Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:

Nocturnal enuresis (NE) is a psychosocial problem for children and parents. The incidence of Ne is 20% in 5 years old children. Since no single etiology is found for disorder, various therapeutic modalities have been used. None of which could cure enuresis entirely. Two types of treatment are considered: Pharamacologic & nonpharmacologic. A prospective experimental study in the level of clinical trial in 98 children aged 5-15 years who have NE underwent for 1 month of therapy with imiperamine in 49 and desmopressin in 49 no. of patient treated with imiperamine 36 children have complete response (73%) (all dry bed), at the 3 months follow up 20 children have recurrence. Ammong patients treated with dessmopressin, 31 children have complete response (63%). Recueernce rate after 3 months is 17 cases. Our results didn’t indicate any statistical difference between imipramine & desmopressin in the treatment of N.E. Imipramine is more complicated than desmopressin so that desmppressin is preferred.

Language:
Persian
Published:
Journal of Arak University of Medical Sciences, Volume:4 Issue: 2, 2001
Page:
7
magiran.com/p846950  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!